Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)
China
· Delayed Price · Currency is CNY
15.00
+0.09 (0.60%)
Nov 19, 2024, 3:00 PM CST
Tasly Pharmaceutical Group Company Description
Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally.
It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions.
Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.
Tasly Pharmaceutical Group Co., Ltd
Country | China |
Founded | 1994 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 9,223 |
CEO | Jing Su |
Contact Details
Address: No. 2, Puji East Road Tianjin, 300410 China | |
Phone | 86 22 2673 6999 |
Website | taslypharma.com |
Stock Details
Ticker Symbol | 600535 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE000001C81 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jing Su | GM and Director |
Jie Wei | Chief Financial Officer and Head of Accounting |
Yu Jie | Secretary and Vice President |
Jin Yong Cai | Deputy GM and Employee Representative of the Supervisory Board |
Hongwei Liu | Deputy GM and Vice Chairman of the Supervisory Board |
Shunnan Zhang | Deputy GM and Supervisor |